Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209259 · ClinicalTrials.gov registry record · NA
The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm Illness
A NA study of Arm Illness, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT02209259 is a NA study of Arm Illness that has completed, run by Massachusetts General Hospital. The registered enrollment target is 168 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02209259, a NA study of Arm Illness, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan a prospective randomized study to see whether negative questions affect measures of mood, pain, or disability. A total of 175 patients will participate at Massachusetts General Hospital.
Conditions Studied
Interventions
- OTHER PROMIS Upper Extremity Function
- OTHER Pain intensity
- OTHER PROMIS depression
- OTHER Positive affect negative affect scale (PANAS)
- OTHER standard PCS
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02209259
The ClinicalTrials.gov registry entry for NCT02209259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arm Illness appearing as the primary indexed condition, and to 5 interventions - of which PROMIS Upper Extremity Function is the first listed.
NCT02209259 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02209259 about?
NCT02209259 is a clinical study titled "The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm Illness". The investigators plan a prospective randomized study to see whether negative questions affect measures of mood, pain, or disability. A total of 175 patients will participate at Massachusetts General Hospital.
What is the current status of trial NCT02209259?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2014-05. Estimated completion is 2016-02.
What conditions does trial NCT02209259 study?
This clinical trial studies the following conditions: Arm Illness.
What interventions are being tested in trial NCT02209259?
The interventions under investigation include: PROMIS Upper Extremity Function (OTHER), Pain intensity (OTHER), PROMIS depression (OTHER), Positive affect negative affect scale (PANAS) (OTHER), standard PCS (OTHER).
Who is sponsoring clinical trial NCT02209259?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02209259 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.